NORTIS, INC.

Basic Information

17280 Woodinville-Redmond Rd. NE
Suite B-828
Woodinville, WA, 98072-9088

http://www.nortisbio.com/

Company Profile

Nortis is a biotech company with locations in Seattle and Woodinville, WA. Founded by former UW faculty and spun-out in 2011, Nortis has developed technologies for generating small segments of human tissues and organs in microfluidic chips for the in vitro study of human health and disease. The technology represents an important alternative to lab animals in pharmaceutical drug development, where more predictive preclinical test models are urgently needed to increase clinical trial success. This advance will overcome a large barrier to developing therapeutic drugs and vaccines for diseases like cancer, diabetes, Alzheimer’s disease, infectious diseases, cardiovascular disease, and stroke.

Additional Details

Field Value
DUNS: 963398826
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 21


  1. IGF OT IGF SBIR PHASE II TOPIC TITLE A VASCULARIZED TUMOR MICROENVIRONMENT ASSAY FOR THE SCREENING OF ANTI CANCER DRUGS

    Amount: $1,988,728.00

    Not Available

    SBIR Phase II 2015 Department of Health and Human Services National Institutes of Health
  2. A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier

    Amount: $225,000.00

    DESCRIPTION provided by applicant The blood brain barrier BBB is a tight barrier formed by microvessels and capillaries that control the passage of nutrients fluids metabolic products and drug ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  3. Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test

    Amount: $1,509,974.00

    DESCRIPTION provided by applicant Abnormal angiogenesis the growth of new blood vessels from existing vasculature plays a central role in more than seventy major health conditions afflicting over ...

    SBIR Phase II 2014 Department of Health and Human Services National Institutes of Health
  4. SBIR TOPIC 314: DEVELOPMENT OF A HUMAN TISSUE CULTURE SYSTEM THAT MIMICS THE TUMO

    Amount: $299,986.00

    Not Available

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government